Articles |
From the Laboratory of Experimental Pathology (P.P., Y.M.), Montreal Heart Institute, the Laboratory of Cell Biology of Hypertension (J.T.), Research Center, Hôtel-Dieu de Montréal, and the University of Montreal, Montreal, Quebec, Canada.
Correspondence to Yahye Merhi, Montreal Heart Institute, 5000 Belanger Street East, Montreal, Quebec H1T 1C8, Canada.
Abstract Nitric oxide has been reported to modulate platelet and neutrophil interactions with the arterial wall. In this study, we investigated the effects of the nitric oxide donor 3-morpholino-sydnonimine (SIN-1) on platelet and neutrophil adhesion, and the vasomotor response, in a porcine model of angioplasty. Carotid arterial injury was produced by balloon dilation in control (n=10) and treated (SIN-1; 10 µg/kg + 1 µg/kg/min, IV) (n=8) pigs. At the site of deep arterial injury, the average platelet adhesion was 53.6±11.3x106/cm2 in the control animals and was significantly inhibited by more than 70%, to 15.1±4.1x106/cm2 (P<.01), by SIN-1. Neutrophil adhesion was also decreased by SIN-1, from 255.9±29.7 to 101.8±19.7x103/cm2 (P<.001). Mural thrombosis was found in 12 (71%) of the 17 injured arteries in the control group but in only 2 (17%) of the 12 injured arteries in the SIN-1treated group (P<.05). Concomitantly, SIN-1 reduced platelet and neutrophil adhesion to the site of endothelial injury distally. The internal diameter of the carotid arteries was similar between the two groups before dilation but was 40% greater at the site of endothelial injury distally in SIN-1treated animals after dilation (P<.05), as compared with controls. Accordingly, postangioplasty vasoconstriction was significantly attenuated from 46.3±2.9% in control pigs to 32.5±4.8% (P<.05) in SIN-1treated animals. The beneficial effects of SIN-1 were associated with inhibition of neutrophil-mediated whole blood aggregation and of neutrophil-endothelium interactions. The potent antiadhesive and antithrombotic properties of SIN-1 in vivo were confirmed in ex vivo superfusion experiments. These results indicate that administration of a nitric oxide donor may be effective in preventing the acute pathophysiological responses to arterial injury by angioplasty.
Key Words: carotid arteries thrombosis nitric oxide blood platelets neutrophils
This article has been cited by other articles:
![]() |
S. H. Baek, J. A. Hrabie, L. K. Keefer, D. Hou, N. Fineberg, R. Rhoades, and K. L. March Augmentation of Intrapericardial Nitric Oxide Level by a Prolonged-Release Nitric Oxide Donor Reduces Luminal Narrowing After Porcine Coronary Angioplasty Circulation, June 11, 2002; 105(23): 2779 - 2784. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-G. Bienvenu, J.-F. Tanguay, J.-F. Theoret, A. Kumar, R. G. Schaub, and Y. Merhi Recombinant Soluble P-Selectin Glycoprotein Ligand-1-Ig Reduces Restenosis Through Inhibition of Platelet-Neutrophil Adhesion After Double Angioplasty in Swine Circulation, February 27, 2001; 103(8): 1128 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Jeremy, D. Rowe, A. M. Emsley, and A. C. Newby Nitric oxide and the proliferation of vascular smooth muscle cells Cardiovasc Res, August 15, 1999; 43(3): 580 - 594. [Full Text] [PDF] |
||||
![]() |
Y. Merhi, P. Provost, P. Chauvet, J.-F. Theoret, M. L. Phillips, and J.-G. Latour Selectin Blockade Reduces Neutrophil Interaction With Platelets at the Site of Deep Arterial Injury by Angioplasty in Pigs Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 372 - 377. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |